risks of glp 1 inhibitors GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity Treatment of High-Risk Patients with

Gentle movement on low-energy days helps maintain metabolism and consistency

Vasavada A, Patel P, Sanghavi DK

They work by: Slowing stomach emptying Increasing insulin secretion Decreasing appetite Medications in this category include: Semaglutide (brand names: Ozempic, Wegovy) Liraglutide (Saxenda, Victoza) Tirzepatide (Mounjaro technically a dual GIP/GLP-1 agonist) In recent years, theyve been widely used off-label for weight losseven among women trying to conceive

She writes from a non-clinical, educational perspective with the intention to inform and empower, not to diagnose or prescribe

Are taking other vitamin supplements

Moghaddam E, Vogt JA, Wolever TM